Finance
Results: 433-444 of 40553

Alkermes to Present Additional Data From Vibrance-1 Phase 2 Study of Alixorexton in Patients with Narcolepsy Type 1 at the American Academy of Neurology (AAN) 2026 Annual Meeting

After 35 Years with Parkinson's Disease and a Life-Threatening Infection, One Patient Reclaimed Independent Living

Miami International Holdings Announces Date of First Quarter 2026 Earnings Release and Conference Call






